Clinical Dosimetry Tool Implementation of I-131 MIBG Therapy for Pheochromocytoma and Paraganglioma

被引：0
|
作者：
Franco, R. Perez [1 ]
Pugachev, A. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
MEDICAL PHYSICS | 2020年 / 47卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
PO-GeP-I-5
引用
收藏
页码：E519 / E519
页数：1
相关论文
共 50 条
  • [21] 131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumours - a single-centre study
    Kotecka-Blicharz, Agnieszka
    Hasse-Lazar, Kornelia
    Handkiewicz-Junak, Daria
    Gawlik, Tomasz
    Pawlaczek, Agnieszka
    Oczko-Wojciechowska, Malgorzata
    Michalik, Barbara
    Szpak-Ulczok, Sylwia
    Krajewska, Jolanta
    Jurecka-Lubieniecka, Beata
    Jarzab, Barbara
    ENDOKRYNOLOGIA POLSKA, 2018, 69 (03) : 246 - 251
  • [22] PHEOCHROMOCYTOMA AND FUNCTIONING PARAGANGLIOMA IN CHILDHOOD AND ADOLESCENCE - ROLE OF I-131 METAIODOBENZYLGUANIDINE
    KHAFAGI, FA
    SHAPIRO, B
    FISCHER, M
    SISSON, JC
    HUTCHINSON, R
    BEIERWALTES, WH
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1991, 18 (03): : 191 - 198
  • [23] 131-METAIODOBENZYLGUANIDINE (131 MIBG) THERAPY FOR PATIENTS WITH MALIGNANT PHEOCHROMOCYTOMA AND PARAGANGLIOMA: THE ISRAELI EXPERIENCE
    Shilkrut, M.
    Bar-Deroma, R.
    Bar Sela, G.
    Kuten, A.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S303 - S303
  • [24] Radiation Dosimetry, Pharmacokinetics, and Safety of Ultratrace™ Iobenguane I-131 in Patients with Malignant Pheochromocytoma/Paraganglioma or Metastatic Carcinoid
    Coleman, R. Edward
    Stubbs, James B.
    Barrett, John A.
    de la Guardia, Miguel
    LaFrance, Norman
    Babich, John W.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (04) : 469 - 475
  • [25] Adverse Prognostic Factors in Patients Refractory Pheochromocytoma and Paraganglioma After 131I-metaiodinebenzylguanidine (131I-mIBG) Therapy
    Hiromasa, T.
    Wakabayashi, H.
    Kayano, D.
    Inaki, A.
    Toratani, A.
    Akatani, N.
    Watanabe, S.
    Yamase, T.
    Kunita, Y.
    Mori, H.
    Saito, S.
    Takata, A.
    Kinuya, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S568 - S569
  • [26] Hepatic absorbed radiation dosimetry during I-131 Metaiodobenzylguanadine (MIBG) therapy for refractory neuroblastoma
    Kenneth F. Koral
    John P. Huberty
    Bill Frame
    Katherine K. Matthay
    John M. Maris
    Denise Regan
    Daniel Normolle
    Gregory A. Yanik
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 2105 - 2112
  • [27] METHODOLOGY AND DOSIMETRY IN ADRENAL-MEDULLARY IMAGING WITH I-131 MIBG
    LINDBERG, S
    FJALLING, M
    JACOBSSON, L
    JANSSON, S
    TISELL, LE
    JOURNAL OF NUCLEAR MEDICINE, 1988, 29 (10) : 1638 - 1643
  • [28] Hepatic absorbed radiation dosimetry during I-131 Metaiodobenzylguanadine (MIBG) therapy for refractory neuroblastoma
    Koral, Kenneth F.
    Huberty, John P.
    Frame, Bill
    Matthay, Katherine K.
    Maris, John M.
    Regan, Denise
    Normolle, Daniel
    Yanik, Gregory A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (11) : 2105 - 2112
  • [29] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Sudbrock, Ferdinand
    Schmidt, Matthias
    Simon, Thorsten
    Eschner, Wolfgang
    Berthold, Frank
    Schicha, Harald
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1279 - 1290
  • [30] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Ferdinand Sudbrock
    Matthias Schmidt
    Thorsten Simon
    Wolfgang Eschner
    Frank Berthold
    Harald Schicha
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1279 - 1290
12345